Biolife Solutions Inc
BLFS- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0000834365
No open-market purchases or sales by Biolife Solutions Inc insiders were filed in the last 90 days; 216 institutions reported holding it in 13F filings for Q2 2026, worth $1.40B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Biolife Solutions Inc as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 195
- +8 vs. Q1 2025
- Shares held
- 49.9M
- +1.71M (+3.6%) vs. Q1 2025
- Total value
- $1.07B
- −$50.6M (−4.5%) vs. Q1 2025
- New holders
- 33
- 79 more added
- Sold out
- 25
- 52 more reduced
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BLFS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 216 | $1.40B |
| Q1 2026 | 187 | $951.6M |
| Q4 2025 | 187 | $1.18B |
| Q3 2025 | 192 | $1.23B |
| Q2 2025 | 195 | $1.07B |
| Q1 2025 | 189 | $1.12B |
| Q4 2024 | 181 | $1.21B |
| Q3 2024 | 195 | $1.13B |
| Q2 2024 | 164 | $1.00B |
| Q1 2024 | 149 | $823.5M |
| Q4 2023 | 140 | $737.7M |
| Q3 2023 | 153 | $601.8M |
| Q2 2023 | 156 | $896.7M |
| Q1 2023 | 169 | $842.8M |
| Q4 2022 | 165 | $694.9M |
| Q3 2022 | 174 | $873.9M |
| Q2 2022 | 160 | $509.1M |
| Q1 2022 | 164 | $799.1M |
| Q4 2021 | 169 | $1.31B |
| Q3 2021 | 165 | $1.34B |
| Q2 2021 | 132 | $1.24B |
| Q1 2021 | 133 | $915.0M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Biolife Solutions Inc; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −18,826−100.0% | Sold out |
| Mesirow Financial Investment Management, Inc. | 0 | $0 | 0.00% | −17,120−100.0% | Sold out |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −13,089−100.0% | Sold out |
| Natixis Advisors, L.P. | 0 | $0 | 0.00% | −12,295−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −12,283−100.0% | Sold out |
| Capula Management Ltd | 0 | $0 | 0.00% | −12,138−100.0% | Sold out |
| Connors Investor Services Inc | 0 | $0 | 0.00% | −9,200−100.0% | Sold out |
| Centaurus Financial, Inc. | 0 | $0 | 0.00% | −6,600−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −323−100.0% | Sold out |
| Mather Group, LLC. | 0 | $0 | 0.00% | −124−100.0% | Sold out |
| Millstone Evans Group, LLC | 0 | $0 | 0.00% | −89−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| Rise Advisors, LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| TD Capital Management LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Glenmede Trust Co NA | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |